Ginsenoside‐Engineered Lipid Nanoparticles in Microbeads Enable Oral siRNA Delivery and Targeted Therapy for Ulcerative Colitis
Authors:
- 7 February 2026
- journal article
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (37)
Abstract
Small interfering RNAs (siRNAs) have emerged as promising therapeutics for ulcerative colitis (UC) owing to their potent anti‐inflammatory effects and favorable biocompatibility. However, effective oral siRNA delivery remains challenging due to limited inflammatory cell targeting, inefficient endosomal escape, and rapid degradation in the gastrointestinal tract. To overcome these barriers, we developed a nano‐in‐micro modular microbead system for colon‐targeted delivery of siRNA against tumor necrosis factor‐α (TNF‐α). This platform integrates two key components: (i) a library of ginsenoside‐based lipid nanoparticles (LNPs) generated by screening natural sterol analogues, among which ginsenoside Rg3‐based LNPs (Rg3@siTNF‐α) were identified as optimal carriers, enabling enhanced macrophage targeting via glucose transporter‐1–mediated recognition and promoting endosomal escape by attenuating Niemann–Pick C1 (NPC1)–dependent recycling; and (ii) a calcium alginate (CA) shell that encapsulated Rg3@siTNF‐α to form microbeads (CA@Rg3@siTNF‐α), protecting the LNPs from premature degradation in the upper gastrointestinal tract. Upon colon‐specific dissolution, CA@Rg3@siTNF‐α released Rg3@siTNF‐α, facilitating efficient macrophage uptake, rapid endosomal escape, and lipase‐responsive siRNA release. Consequently, the microbeads alleviated UC by suppressing inflammation and oxidative stress, restoring epithelial barrier integrity, and rebalancing the gut microbiota. Collectively, this work presents a spatiotemporally controlled strategy for oral siRNA delivery with multi‐mechanistic therapeutic actions.Keywords
Funding Information
- National Natural Science Foundation of China (82474205)
- Liaoning Revitalization Talents Program (XLYC22202019)
This publication has 34 references indexed in Scilit:
- Polydopamine Nanodots Ameliorate Inflammatory Bowel Disease by Restoring Redox Homeostasis and Intestinal MicroenvironmentAdvanced Science, 2025
- Optimization and evaluation of gastroresistant microparticles designed for siRNA oral deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2024
- Nanoassemblies Derived from Natural Flavonoid Compounds as New Antioxidant Oral Preparations for Targeted Inflammatory Bowel Disease TherapyAdvanced Functional Materials, 2023
- Ginsenoside PPD inhibit the activation of HSCs by directly targeting TGFβR1International Journal of Biological Macromolecules, 2022
- The growth of siRNA-based therapeutics: Updated clinical studiesBiochemical Pharmacology, 2021
- Ginsenoside Rb1 and mitochondria: A short review of the literatureMolecular and Cellular Probes, 2019
- The application of in silico drug-likeness predictions in pharmaceutical researchAdvanced Drug Delivery Reviews, 2015
- Calcium alginate-carboxymethyl cellulose beads for colon-targeted drug deliveryInternational Journal of Biological Macromolecules, 2015
- Impaired Autophagy in the Lipid-Storage Disorder Niemann-Pick Type C1 DiseaseCell Reports, 2013
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009